Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review
Diabetic retinopathy (DR) is classically defined by its vascular lesions and damage in the neurons of the retina. The cellular and clinical elements of DR have many features of chronic inflammation. Understanding the individual cell-specific inflammatory changes in the retina may lead to novel thera...
Saved in:
Main Authors: | Lei Lu, Ying Jiang, Ravindran Jaganathan, Yanli Hao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2018/1694187 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacotherapies for Obesity: Past, Current, and Future Therapies
by: Lisa L. Ioannides-Demos, et al.
Published: (2011-01-01) -
Review of Current First-Line Pharmacotherapy Strategies for Thyroid Eye Disease
by: Julia Ryniecka, et al.
Published: (2025-01-01) -
Recent Advances in Pharmacotherapy Development for Abdominal Aortic Aneurysm
by: Koichi Yoshimura, et al.
Published: (2012-01-01) -
Editorial: Advances in the pharmacotherapy of chronic pelvic pain conditions
by: Elena Lucarini, et al.
Published: (2025-01-01) -
Weight Considerations in Pharmacotherapy for Type 2 Diabetes
by: Vicky Cheng, et al.
Published: (2011-01-01)